10 April 2006
Epistatic effects between two genes in the renin-angiotensin system and systolic blood pressure and coronary artery calcification.
Sharon L.R. Kardia, Lawrence F. Bielak, Leslie A. Lange, James M. Cheverud, Eric Boerwinkle, Stephen T. Turner, Patrick F. Sheedy II, Patricia A. PeyserMed Sci Monit 2006; 12(4): CR150-158 :: ID: 448900
Abstract
Background: Coronary artery calcification (CAC) is an important indicatorof future coronary artery disease events. Since elevated blood pressure (BP) is an important predictorof CAC, genetic polymorphisms in the renin-angiotensin system and their interaction may play a role inexplaining CAC quantity variation. Material/Methods: As part of the Epidemiology of Coronary Artery CalcificationStudy, 166 asymptomatic women and 166 asymptomatic men were genotyped for the insertion/deletion polymorphismin the angiotensin-converting enzyme (ACE) gene and the -6 promoter polymorphism of the angiotensinogen(AGT) gene. We used a novel method to detect gene-gene interaction and compared it to the standard two-wayanalysis of variance (ANOVA) method. Results: Based on a two-way ANOVA model, there was no evidence forepistasis for either systolic BP or CAC in either men or women. However, using a novel method, we foundevidence of significant gene-gene interaction in systolic BP in men and gene-gene interaction in bothsystolic BP levels and CAC quantity in women. Conclusions: Our study demonstrates that new methods ofassessing epistasis maybe important in understanding the complex genetics of systolic blood pressureas well as subclinical coronary atherosclerosis.
Keywords: Epistasis, Genetic, Renin-Angiotensin System - genetics, Promoter Regions, Genetic, Polymorphism, Genetic, Peptidyl-Dipeptidase A - genetics, Genotype, Aged, 80 and over, DNA - genetics, Coronary Vessels - pathology, Coronary Artery Disease - genetics, Calcinosis - genetics, Blood Pressure - genetics, Base Sequence, Angiotensinogen - genetics
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952